Top Smart Score Stocks
Analysts' Top Stocks
Insiders' Hot Stocks
Daily Stock Ratings
Daily Insider Transactions
My Portfolio Analysis
My Public Profile
Find & Follow Experts
Top 25 Wall Street Analysts
Top 25 Financial Bloggers
Top 25 Corporate Insiders
Top 25 Hedge Fund Managers
Top Individual Investors
Ideas & Insights
Calendars & Events
Stock Market Holidays
Plans & Pricing
Billionaire Ray Dalio Places Bet on 3 “Strong Buy” Stocks
When billionaire financier Ray Dalio makes a move, Wall Street pays attention. Dalio, who got his start working on the...
Feb 21, 2021
AbbVie’s 4Q Profit Tops Analysts’ Estimates; Shares Gain
AbbVie reported 4Q diluted EPS of $2.92, which came in ahead of analysts’ estimates of $2.86. Revenues in...
Feb 03, 2021
3 ‘Strong Buy’ Stocks With at Least 5% Dividend Yield
Americans went to the polls today under the shadow of a resurging pandemic, with a substantial increase in...
D. H. Taylor
Nov 03, 2020
AbbVie Submits US, EU Rinvoq Applications For Atopic Dermatitis
AbbVie (ABBV) has announced that it has submitted applications to the U.S. Food and Drug Administration (FDA) and European...
Oct 20, 2020
AbbVie Inks Deal To Develop, Sell I-Mab’s Cancer Therapy
AbbVie announced that it has signed an exclusive global collaboration agreement with I-Mab to develop and sell the...
Sep 06, 2020
AbbVie To Face US House Committee Subpoena In Drug-Pricing Probe
The US House Oversight Committee intends to issue a subpoena to AbbVie after the drugmaker failed to provide...
Sep 02, 2020
AbbVie vs Biogen: Which Drugmaker Scores A ‘Strong Buy’ Street Consensus?
The COVID-19 pandemic has led to a wake-up call for governments, as they realize the significant investment required...
Aug 26, 2020
Allergan Withdraws EU, Japan Filing For Macular Degeneration Drug
AbbVie’s (ABBV) Allergan has told Molecular Partners that it will withdraw application filings with both the European Medicines...
Jul 20, 2020
AbbVie, Roche’s AML Therapy Shows Significant Survival Benefits
AbbVie (ABBV) and Roche’s (RHHBY) Genentech have revealed positive results from the Phase III VIALE-A study, evaluating Venclexta (venetoclax)...
Jun 14, 2020
Genmab Shares Rise 5% In Pre-Market On Oncology Partnership With AbbVie
Shares in Genmab A/S (GMAB) rose in pre-market trading after announcing a collaboration agreement with AbbVie (ABBV) to...
Jun 10, 2020
AbbVie’s Rinvoq Beats Bristol-Myers’ Orencia In New Rheumatoid Arthritis Data
Biopharma AbbVie (ABBV) has announced positive Phase 3 data from a Select-Choice clinical trial, comparing Rinvoq (upadacitinib, 15...
Jun 08, 2020
AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy
AbbVie (ABBV) announced on Friday that it has entered into a collaboration to develop a novel antibody therapeutic...
Jun 07, 2020
AbbVie Seeks Rinvoq Approval For Psoriatic Arthritis In US, Europe
Drugmaker AbbVie (ABBV) has announced that it has submitted applications for a new indication for Rinvoq (upadacitinib; 15 mg,...
Jun 02, 2020
Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead
After several postponed decisions, Mylan Inc (MYL) has announced that it is moving forward with a Botox biosimilar...
Jun 02, 2020
Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor
AbbVie (ABBV) announced on Monday that it has entered into a partnership with Jacobio Pharmaceuticals, to jointly develop...
Jun 01, 2020
JPMorgan: 2 Stocks to Snap Up Now (And 1 to Avoid)
Times right now are unprecedented. The COVID-19 pandemic, the overarching government responses, the social and economic shutdowns –...
May 20, 2020